Intelligence / Healthtech / New Clinical Trials
ClinicalLIVEUpdated 18 Nov 2026
New Clinical Trials
Clinical trials companies registered in the last 30 days, worldwide, with the sponsor, phase and countries.
Sources: ClinicalTrials.gov · Rebuilt weekly · Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase.
Trials
777
in the 30 days to 2026-11-18
Added in 30 days
777
to 18 Nov 2026
Top country
United States
192 · 25% of the list
Phase covered
8
distinct values
Snapshot · 18 Nov 2026
Explore all 777 Growth
By month
777
Signals
What the register says this week, and why it matters if you sell into it.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
- 174 of the listed studies are device, diagnostic or digital-health studies (no drug phase).
- A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
PostedSponsorStudyPhaseStatus
18 Nov 2026Diabetes Free, Inc.GermanyDual-targeting of B & T Cell Pathways Evaluation TrialPhase 1, Phase 2Recruiting18 Nov 2026Gaia AGGermanyInvestigating the Effectiveness of Calisda, a Digital Health Intervention for Patients With Menopause SymptomsNot applicableNot Yet Recruiting16 Nov 2026Boehringer IngelheimGermanyA Study to Compare How Survodutide is Taken up by the Body When Given in 2 Formulations to People With Overweight or ObesityPhase 1Not Yet Recruiting16 Nov 2026Finzelberg GmbH & Co. KGGermany, IrelandEffects of a Botanical Extract on Cognitive Performance and Cerebral Blood Flow in Healthy AdultsNot applicableNot Yet Recruiting13 Nov 2026Cutempa Medical AGGermanySilica-Based Wound Treatment (Curi01) Plus Standard Care Versus Standard Care Alone for Chronic Diabetic Foot WoundsNot applicableRecruiting12 Nov 2026Aponia Laboratories, Inc.United States, GermanyEffect of S-Ibuprofen Gel on Pain in Acute Soft Tissue ContusionsPhase 3Recruiting12 Nov 2026Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, GermanyGermanyStudy of Multiple Ascending Doses (MAD) of M5542 in Participants With Moderate and Severe EczemaPhase 1Not Yet Recruiting12 Nov 2026Novo Nordisk A/SUnited States, Argentina, AustraliaAMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide in People With Type 2 Diabetes Treated With Metformin, SGLT2i, or BothPhase 3Not Yet Recruiting12 Nov 2026Novo Nordisk A/SUnited States, Brazil, ChinaA Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease Treated With Once Daily Basal Insulin Alone or in Combination With Metformin, SGLT2i, or BothPhase 3Not Yet Recruiting10 Nov 2026Boehringer IngelheimBelgium, France, GermanyA Study to Test Obrixtamig Treatment in People With Different Types of Advanced Cancer Who Took Part in a Previous Study With ObrixtamigPhase 3Not Yet Recruiting9 Nov 2026Boehringer IngelheimUnited States, Belgium, FinlandA Study to Test Whether BI 3810477 Helps People With Idiopathic Pulmonary Fibrosis When Taken With or Without Standard TreatmentPhase 2Not Yet Recruiting5 Nov 2026Novo Nordisk A/SUnited States, Argentina, AustraliaA Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and ObesityPhase 3Not Yet Recruiting4 Nov 2026Boehringer IngelheimUnited States, Argentina, AustriaA Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)Phase 3Not Yet Recruiting30 Oct 2026Boehringer IngelheimGermanyA Study to Test How Well Different Doses of BI 3821001 Are Tolerated by Healthy PeoplePhase 1Recruiting30 Oct 2026Bosch Quantum Sensing GmbHGermanyMagnetic Field Maps With NV Application Kit MCGRecruiting30 Oct 2026MED-EL Elektromedizinische Geräte GmbHGermanyPost-Market Registry Study for Vibrant Hearing SolutionsEnrolling By Invitation28 Oct 2026Ambulanzpartner Soziotechnologie APST GmbHGermanyRegister for Medical Data, Functional Scales, and Care Outcomes in ALS, SMA, and Other Motor System DisordersRecruiting28 Oct 2026Eli Lilly and CompanyUnited States, Argentina, AustraliaA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular RiskPhase 3Not Yet Recruiting28 Oct 2026MED-EL Elektromedizinische Geräte GmbHAustria, Belgium, GermanyMi2000 TICI Follow-upRecruiting27 Oct 2026Desentum OyGermanySafety, Tolerability And Pharmacodynamics of DM-101PX in Birch Pollen AllergyPhase 1Recruiting27 Oct 2026MED-EL Elektromedizinische Geräte GmbHAustria, Belgium, GermanyMi2000 TICI - Post-market Implantation StudyNot applicableRecruiting27 Oct 2026Otto Bock Healthcare Products GmbHUnited States, GermanyEvaluating the Effects of the EXOPULSE Suit on Mobility, Walking Ability, and Balance in People With Multiple SclerosisNot applicableNot Yet Recruiting27 Oct 2026Swedish Orphan BiovitrumBrazil, Canada, FinlandA Study to Assess the Efficacy and Safety of Pegcetacoplan for the Prevention of Recurrent C3G or Primary IC-MPGN in Kidney Transplant RecipientsPhase 3Recruiting26 Oct 2026Novo Nordisk A/SGermanyA Research Study to Check the Safety of NNC9836-0001 When Given to Healthy Participants and Participants With Type 2 DiabetesPhase 1Recruiting22 Oct 2026Bionime CorporationGermanyEffectiveness and Safety of the RIGHTEST™ CGM System for Blood Glucose Management in Persons With Diabetes MellitusNot applicableCompleted22 Oct 2026Bionime CorporationGermanyRIGHTEST iFree 2 CGM in Pregnant Women With Diabetes StudyNot applicableRecruiting22 Oct 2026Terumo Europe N.V.Austria, Belgium, GermanyEvaluation of Safety, Performance and Usability of the TR Band DISTAL Device for Hemostasis Following Distal Radial Access in Coronary ProceduresNot Yet Recruiting20 Oct 2026Ascilion ABGermanyMicroneedle-based ISF Sampling TechniqueNot applicableNot Yet Recruiting20 Oct 2026Mitra BioBelgium, Germany, SpainDevelopment and Multi-Centre Validation of a Novel Non-Invasive Melanoma Molecular Diagnostic TestRecruiting// How AOS uses this